Abstract:Background: Non-small cell lung cancer (NSCLC) is the most common histological type of lung cancer, and one of the malignant tumor with the highest mortality. As the main part of the optical molecular imaging probe, peptide can realize the early screening and diagnosis of tumor and improve the survival rate of patients. The aim of this study was to screen the small-molecule peptide that highly binds to NSCLC NCI-H1299 cells using in vivo phage display technology and to identify their binding specificity by in vitro experiment. Methods: To prepare a tumor-bearing nude mouse model of NCI-H1299 cells, after 3 rounds of in vivo screening with Ph.D.-C7CTM Peptide Library, phage clones were randomly picked, using immunohistochemistry and enzyme-linked immunosorbent assay (ELISA) to identify the affinity of phage clones to NCI-H1299 cells. The positive monoclonal phages DNA was extracted and sequenced to obtain the amino acid sequence of the peptides. The peptides with the highest repetition rate was chemically synthesized and labeled with fluorescein (FITC) to prepare optical molecular probe. We preliminary identified the specificity of the probe binding to lung cancer cells by in vitro experiment. Results: After three rounds of in vivo screening, the phages enrichment rate was 341.3 times compared with the first round. Immunohistochemical staining showed that with the increase of screening times, the phages binding to tumor tissues continued to increase, and the binding amount was significantly higher than normal tissues; ELISA results showed that 20 clones among the 30 randomly selected phage clones were positive. After sequencing, the peptide with the highest repetition rate was synthesized and named NSP1; Methyl thiazolyl tetrazolium assay (MTT) and would healing assay showed that NSP1 will not affect cell proliferation and migration. Flow cytometry and immunofluorescence showed specific binding of NSP1 to NCI-H1299 cells. Conclusions: We successfully obtained the peptide NSP1 that specifically binds to lung cancer NCI-H1299 cells by in vivo phage display, which provide a theoretical basis for NSCLC early diagnosis and targeted therapy.

Panning and Identification of a Colon Tumor Binding Peptide from a Phage Display Peptide Library

Identification of a specific peptide binding to colon cancer cells from a phage-displayed peptide library

Screening and Identification of A Targeting Peptide to Hepatocarcinoma from A Phage Display Peptide Library

Screening of a Specific Peptide Binding to VPAC1 Receptor from a Phage Display Peptide Library.

In vitro panning of a targeting peptide to hepatocarcinoma from a phage display peptide library.

Screening and Identification of a Renal Carcinoma Specific Peptide from a Phage Display Peptide Library

Identification of Tumor Associated Single-Chain Fv by Panning and Screening Antibody Phage Library Using Tumor Cells

Identification of a peptide binding to cancer antigen Kita‐kyushu lung cancer antigen 1 from a phage‐display library

Screening and Identification of a Specific Peptide Binding to Hepatocellular Carcinoma Cells from a Phage Display Peptide Library

Specific Phage-Displayed Peptides Binding to Tumor Vasculature

Identification of a Glypican-3 Binding Peptide From a Phage-Displayed Peptide Library for PET Imaging of Hepatocellular Carcinoma

Screening and identification of a specific peptide binding to breast cancer cells from a phage-displayed peptide library

Rational Identification of a Colorectal Cancer Targeting Peptide through Phage Display

Screening of Molecular Markers for Early Diagnosis of Colorectal Cancer by Phage-Peptide Library

Phage-based peptides for pancreatic cancer diagnosis and treatment: alternative approach

Screening and Identification of a Phage Display Derived Peptide That Specifically Binds to the CD44 Protein Region Encoded by Variable Exons.

Phage Display Peptide Library Technology's Application in the Diagnosis and Therapy of Tumor

In Vivo Screening with Ph . D .7 TM and Identification of Ovarian Cancer A 2780 Cell Targeted

[Screening and Identification of the Peptides Specifically Binding to Human Non-small Cell Lung Cancer NCI-H1299 Cells]

Selection and Preliminary Identification of Hepatocarcinoma-Binding and Internalizing Peptide

Tumor-Targeting Peptides Search Strategy for the Delivery of Therapeutic and Diagnostic Molecules to Tumor Cells